

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of relaxation of muscle (GO:1901077) | 8.29939578 |
| 2 | actin filament-based movement (GO:0030048) | 7.80768499 |
| 3 | creatine metabolic process (GO:0006600) | 7.73947677 |
| 4 | striated muscle contraction (GO:0006941) | 7.52530823 |
| 5 | response to muscle activity (GO:0014850) | 7.43055628 |
| 6 | myofibril assembly (GO:0030239) | 7.40879560 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.29689043 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.94837058 |
| 9 | skeletal muscle fiber development (GO:0048741) | 6.84145449 |
| 10 | sarcomere organization (GO:0045214) | 6.72835900 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.42186377 |
| 12 | myotube cell development (GO:0014904) | 6.16668944 |
| 13 | glycogen catabolic process (GO:0005980) | 6.13897083 |
| 14 | skeletal muscle adaptation (GO:0043501) | 6.12230412 |
| 15 | response to inactivity (GO:0014854) | 6.05836294 |
| 16 | plasma membrane repair (GO:0001778) | 5.83598267 |
| 17 | muscle contraction (GO:0006936) | 5.83118222 |
| 18 | glucan catabolic process (GO:0009251) | 5.77850209 |
| 19 | cardiac myofibril assembly (GO:0055003) | 5.45890279 |
| 20 | cellular polysaccharide catabolic process (GO:0044247) | 5.42286663 |
| 21 | glycogen biosynthetic process (GO:0005978) | 5.30459791 |
| 22 | glucan biosynthetic process (GO:0009250) | 5.30459791 |
| 23 | cardiac muscle contraction (GO:0060048) | 5.28678648 |
| 24 | muscle system process (GO:0003012) | 5.19236217 |
| 25 | NADH metabolic process (GO:0006734) | 5.18646715 |
| 26 | actomyosin structure organization (GO:0031032) | 5.16549343 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.11545989 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 5.11229606 |
| 29 | muscle fiber development (GO:0048747) | 5.06491212 |
| 30 | regulation of actin filament-based movement (GO:1903115) | 4.93496662 |
| 31 | skeletal muscle tissue development (GO:0007519) | 4.89482911 |
| 32 | polysaccharide catabolic process (GO:0000272) | 4.88800093 |
| 33 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.81863661 |
| 34 | skeletal muscle tissue regeneration (GO:0043403) | 4.71830987 |
| 35 | striated muscle adaptation (GO:0014888) | 4.53676561 |
| 36 | fructose metabolic process (GO:0006000) | 4.50783534 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 4.47273266 |
| 38 | 2-oxoglutarate metabolic process (GO:0006103) | 4.37293481 |
| 39 | muscle organ morphogenesis (GO:0048644) | 4.36498017 |
| 40 | glycogen metabolic process (GO:0005977) | 4.31172416 |
| 41 | muscle cell cellular homeostasis (GO:0046716) | 4.29985106 |
| 42 | striated muscle hypertrophy (GO:0014897) | 4.27188451 |
| 43 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.25173198 |
| 44 | glucan metabolic process (GO:0044042) | 4.22802984 |
| 45 | cellular glucan metabolic process (GO:0006073) | 4.22802984 |
| 46 | response to activity (GO:0014823) | 4.16022294 |
| 47 | IMP metabolic process (GO:0046040) | 4.14172186 |
| 48 | gluconeogenesis (GO:0006094) | 4.10541408 |
| 49 | muscle cell fate commitment (GO:0042693) | 4.07986475 |
| 50 | positive regulation of myotube differentiation (GO:0010831) | 4.01500442 |
| 51 | tricarboxylic acid cycle (GO:0006099) | 3.96562755 |
| 52 | muscle structure development (GO:0061061) | 3.92081452 |
| 53 | muscle organ development (GO:0007517) | 3.91003748 |
| 54 | muscle tissue morphogenesis (GO:0060415) | 3.90710302 |
| 55 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.88652892 |
| 56 | striated muscle atrophy (GO:0014891) | 3.88114944 |
| 57 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.87820551 |
| 58 | striated muscle cell development (GO:0055002) | 3.86086611 |
| 59 | carnitine shuttle (GO:0006853) | 3.80692770 |
| 60 | muscle hypertrophy (GO:0014896) | 3.80269790 |
| 61 | regulation of striated muscle contraction (GO:0006942) | 3.76688638 |
| 62 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.75296843 |
| 63 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.70707935 |
| 64 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.70707935 |
| 65 | adult heart development (GO:0007512) | 3.69092613 |
| 66 | hexose biosynthetic process (GO:0019319) | 3.67438556 |
| 67 | muscle adaptation (GO:0043500) | 3.67158839 |
| 68 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.66301598 |
| 69 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.64963410 |
| 70 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.64963410 |
| 71 | myotube differentiation (GO:0014902) | 3.57891845 |
| 72 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.57811687 |
| 73 | neuronal action potential propagation (GO:0019227) | 3.56470701 |
| 74 | myoblast fusion (GO:0007520) | 3.53148949 |
| 75 | muscle atrophy (GO:0014889) | 3.52865517 |
| 76 | cellular carbohydrate catabolic process (GO:0044275) | 3.52481950 |
| 77 | negative regulation of muscle contraction (GO:0045932) | 3.51488334 |
| 78 | ubiquinone biosynthetic process (GO:0006744) | 3.47076063 |
| 79 | cardiac muscle cell development (GO:0055013) | 3.41978531 |
| 80 | succinate metabolic process (GO:0006105) | 3.41609971 |
| 81 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.38460419 |
| 82 | cardiac muscle adaptation (GO:0014887) | 3.35538196 |
| 83 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.35538196 |
| 84 | muscle hypertrophy in response to stress (GO:0003299) | 3.35538196 |
| 85 | muscle cell development (GO:0055001) | 3.31117699 |
| 86 | striated muscle tissue development (GO:0014706) | 3.29099428 |
| 87 | AMP metabolic process (GO:0046033) | 3.28498002 |
| 88 | oxaloacetate metabolic process (GO:0006107) | 3.28221237 |
| 89 | heart process (GO:0003015) | 3.27824734 |
| 90 | heart contraction (GO:0060047) | 3.27824734 |
| 91 | relaxation of muscle (GO:0090075) | 3.27097558 |
| 92 | positive regulation of cation channel activity (GO:2001259) | 3.26801171 |
| 93 | neuromuscular synaptic transmission (GO:0007274) | 3.22332284 |
| 94 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.21558759 |
| 95 | muscle filament sliding (GO:0030049) | 12.8713403 |
| 96 | actin-myosin filament sliding (GO:0033275) | 12.8713403 |
| 97 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.9930593 |
| 98 | skeletal muscle contraction (GO:0003009) | 10.5946591 |
| 99 | actin-mediated cell contraction (GO:0070252) | 10.5455086 |
| 100 | regulation of skeletal muscle contraction (GO:0014819) | 10.2581138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.90738053 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.64901022 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.64899612 |
| 4 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.81602061 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.80038928 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.32625857 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.10599968 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.08604369 |
| 9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.08604369 |
| 10 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.98675690 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.98572359 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87984150 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.52989670 |
| 14 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.36725283 |
| 15 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.27424730 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.20990953 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.14017211 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06991150 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.05370740 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.96950145 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96454522 |
| 22 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.94162315 |
| 23 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.94135299 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91868756 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87788035 |
| 26 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.67631507 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59561479 |
| 28 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.53335330 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47689625 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42490360 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37495565 |
| 32 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.37031142 |
| 33 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30129813 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27437035 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26731119 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26123462 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23126095 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21345054 |
| 39 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.20999967 |
| 40 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.17483850 |
| 41 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.16479321 |
| 42 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.16202233 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15041270 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15029695 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14524098 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14428089 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14047503 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12131782 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11294093 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10908465 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10697223 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10514038 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10134371 |
| 54 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.08501032 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08490949 |
| 56 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02891077 |
| 57 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.02015246 |
| 58 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01921133 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00909115 |
| 60 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97913586 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92686120 |
| 62 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.92599508 |
| 63 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.92159467 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91907392 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91311997 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91276341 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.91145216 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90741766 |
| 69 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90488281 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87868859 |
| 71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87134893 |
| 72 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85546450 |
| 73 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85367292 |
| 74 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83401734 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83143368 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81911726 |
| 77 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81669047 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80915833 |
| 79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79984938 |
| 80 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78509783 |
| 81 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.77680764 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.75203989 |
| 83 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.75103812 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74492549 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74492549 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73865901 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73749692 |
| 88 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.73631868 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73103107 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72983936 |
| 91 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.71686582 |
| 92 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.71541688 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71421126 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.70804597 |
| 95 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.70258535 |
| 96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.69801160 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.69556585 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.69057890 |
| 99 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.68539787 |
| 100 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.67627596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 7.29921214 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 7.23914169 |
| 3 | MP0000751_myopathy | 5.85633298 |
| 4 | MP0000749_muscle_degeneration | 5.80167832 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.35016745 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.78615242 |
| 7 | MP0000747_muscle_weakness | 3.60719552 |
| 8 | MP0005451_abnormal_body_composition | 3.57451727 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.55689084 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.46497485 |
| 11 | MP0004233_abnormal_muscle_weight | 3.21921293 |
| 12 | MP0005369_muscle_phenotype | 3.19959750 |
| 13 | MP0002332_abnormal_exercise_endurance | 3.09489638 |
| 14 | MP0002269_muscular_atrophy | 3.09023236 |
| 15 | MP0004130_abnormal_muscle_cell | 2.98952692 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.97446381 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.87415869 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.80222741 |
| 19 | MP0005330_cardiomyopathy | 2.64801810 |
| 20 | MP0000733_abnormal_muscle_development | 2.23339899 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 2.14269363 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.08013824 |
| 23 | MP0002108_abnormal_muscle_morphology | 1.95156922 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.86099885 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.69974197 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.67496277 |
| 27 | MP0004484_altered_response_of | 1.65256046 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.52777918 |
| 29 | MP0005266_abnormal_metabolism | 1.47910469 |
| 30 | MP0004270_analgesia | 1.40742888 |
| 31 | MP0006138_congestive_heart_failure | 1.40661769 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.38706729 |
| 33 | MP0001544_abnormal_cardiovascular_syste | 1.33415446 |
| 34 | MP0005385_cardiovascular_system_phenoty | 1.33415446 |
| 35 | MP0004510_myositis | 1.32454480 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25351902 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.22902435 |
| 38 | MP0002971_abnormal_brown_adipose | 1.18168184 |
| 39 | MP0001661_extended_life_span | 1.12894429 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.02321967 |
| 41 | MP0005375_adipose_tissue_phenotype | 0.95558055 |
| 42 | MP0005666_abnormal_adipose_tissue | 0.94634359 |
| 43 | MP0002822_catalepsy | 0.92384040 |
| 44 | MP0000003_abnormal_adipose_tissue | 0.91413913 |
| 45 | MP0008775_abnormal_heart_ventricle | 0.88711614 |
| 46 | MP0003137_abnormal_impulse_conducting | 0.85298949 |
| 47 | MP0005670_abnormal_white_adipose | 0.77819597 |
| 48 | MP0003879_abnormal_hair_cell | 0.76793172 |
| 49 | MP0004147_increased_porphyrin_level | 0.73917892 |
| 50 | MP0000372_irregular_coat_pigmentation | 0.69877239 |
| 51 | MP0003828_pulmonary_edema | 0.69228898 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 0.69201503 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 0.68545131 |
| 54 | MP0003045_fibrosis | 0.65747563 |
| 55 | MP0004085_abnormal_heartbeat | 0.64379476 |
| 56 | MP0000266_abnormal_heart_morphology | 0.60700327 |
| 57 | MP0004134_abnormal_chest_morphology | 0.58221744 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.53637019 |
| 59 | MP0004043_abnormal_pH_regulation | 0.52470377 |
| 60 | MP0010030_abnormal_orbit_morphology | 0.51212869 |
| 61 | MP0001299_abnormal_eye_distance/ | 0.50890142 |
| 62 | MP0005083_abnormal_biliary_tract | 0.48924412 |
| 63 | MP0001346_abnormal_lacrimal_gland | 0.48893739 |
| 64 | MP0009672_abnormal_birth_weight | 0.44304426 |
| 65 | MP0004142_abnormal_muscle_tone | 0.43222687 |
| 66 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42673284 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.41382041 |
| 68 | MP0008569_lethality_at_weaning | 0.40002792 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.37539625 |
| 70 | MP0002638_abnormal_pupillary_reflex | 0.37282049 |
| 71 | MP0005535_abnormal_body_temperature | 0.37122134 |
| 72 | MP0005452_abnormal_adipose_tissue | 0.36594388 |
| 73 | MP0005166_decreased_susceptibility_to | 0.36504099 |
| 74 | MP0005332_abnormal_amino_acid | 0.35815688 |
| 75 | MP0002114_abnormal_axial_skeleton | 0.35657522 |
| 76 | MP0000762_abnormal_tongue_morphology | 0.35148299 |
| 77 | MP0002128_abnormal_blood_circulation | 0.35084307 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.33956700 |
| 79 | MP0005334_abnormal_fat_pad | 0.33856297 |
| 80 | MP0009250_abnormal_appendicular_skeleto | 0.31531036 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.31015933 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 0.30243443 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.28676402 |
| 84 | MP0005423_abnormal_somatic_nervous | 0.28639416 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.28557033 |
| 86 | MP0005187_abnormal_penis_morphology | 0.25693401 |
| 87 | MP0003959_abnormal_lean_body | 0.24257235 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.23972486 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 0.23352262 |
| 90 | MP0005165_increased_susceptibility_to | 0.23223935 |
| 91 | MP0001943_abnormal_respiration | 0.22056854 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 0.21134474 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.19017925 |
| 94 | MP0004858_abnormal_nervous_system | 0.16937316 |
| 95 | MP0006276_abnormal_autonomic_nervous | 0.16057156 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 0.14643707 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.13528432 |
| 98 | MP0009115_abnormal_fat_cell | 0.13014941 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.11672839 |
| 100 | MP0008874_decreased_physiological_sensi | 0.11341424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 8.40980435 |
| 2 | Exercise-induced myalgia (HP:0003738) | 8.39202402 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.91764147 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.33931578 |
| 5 | Distal arthrogryposis (HP:0005684) | 5.97428891 |
| 6 | Myopathic facies (HP:0002058) | 5.93865185 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 5.60346223 |
| 8 | EMG: myopathic abnormalities (HP:0003458) | 5.36465140 |
| 9 | Rhabdomyolysis (HP:0003201) | 5.18134148 |
| 10 | Myoglobinuria (HP:0002913) | 5.00421565 |
| 11 | Round ear (HP:0100830) | 4.83082476 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.78811105 |
| 13 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.69421974 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 4.65585138 |
| 15 | Ulnar deviation of the wrist (HP:0003049) | 4.59842392 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 4.53161643 |
| 17 | Rimmed vacuoles (HP:0003805) | 4.49782198 |
| 18 | Neck muscle weakness (HP:0000467) | 4.48296861 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.29906784 |
| 20 | Subaortic stenosis (HP:0001682) | 4.29906784 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.29612080 |
| 22 | Calcaneovalgus deformity (HP:0001848) | 4.17954087 |
| 23 | Muscle stiffness (HP:0003552) | 3.95247191 |
| 24 | Difficulty running (HP:0009046) | 3.90975255 |
| 25 | Increased connective tissue (HP:0009025) | 3.71229994 |
| 26 | Deformed tarsal bones (HP:0008119) | 3.70527221 |
| 27 | Absent phalangeal crease (HP:0006109) | 3.62702493 |
| 28 | Distal lower limb muscle weakness (HP:0009053) | 3.49732613 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.49681754 |
| 30 | Frequent falls (HP:0002359) | 3.43694764 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.40036145 |
| 32 | Myotonia (HP:0002486) | 3.38376350 |
| 33 | Areflexia of lower limbs (HP:0002522) | 3.34598136 |
| 34 | Malignant hyperthermia (HP:0002047) | 3.12905461 |
| 35 | Sudden death (HP:0001699) | 3.10379709 |
| 36 | Abnormal finger flexion creases (HP:0006143) | 3.01625890 |
| 37 | EMG: neuropathic changes (HP:0003445) | 2.98678870 |
| 38 | Bundle branch block (HP:0011710) | 2.88707203 |
| 39 | Generalized muscle weakness (HP:0003324) | 2.86815722 |
| 40 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.68122072 |
| 41 | Progressive muscle weakness (HP:0003323) | 2.52771124 |
| 42 | Distal lower limb amyotrophy (HP:0008944) | 2.51574352 |
| 43 | Slender build (HP:0001533) | 2.50769976 |
| 44 | Bulbar palsy (HP:0001283) | 2.50324977 |
| 45 | Weak cry (HP:0001612) | 2.42907784 |
| 46 | Abnormality of the calcaneus (HP:0008364) | 2.42735854 |
| 47 | Dilated cardiomyopathy (HP:0001644) | 2.42563602 |
| 48 | Scapular winging (HP:0003691) | 2.42139274 |
| 49 | Limb-girdle muscle atrophy (HP:0003797) | 2.38551657 |
| 50 | Hyperkalemia (HP:0002153) | 2.34188161 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.33758493 |
| 52 | Gowers sign (HP:0003391) | 2.29753921 |
| 53 | Spinal rigidity (HP:0003306) | 2.25278058 |
| 54 | Fatigable weakness (HP:0003473) | 2.22983432 |
| 55 | Abnormality of the neuromuscular junction (HP:0003398) | 2.22983432 |
| 56 | Ventricular tachycardia (HP:0004756) | 2.22610859 |
| 57 | Hip contracture (HP:0003273) | 2.09136248 |
| 58 | Muscular dystrophy (HP:0003560) | 2.08004214 |
| 59 | Proximal amyotrophy (HP:0007126) | 2.07689345 |
| 60 | Lipoatrophy (HP:0100578) | 2.07336400 |
| 61 | Waddling gait (HP:0002515) | 2.03480297 |
| 62 | Abnormality of the foot musculature (HP:0001436) | 2.02060445 |
| 63 | Muscle fiber inclusion bodies (HP:0100299) | 11.4576500 |
| 64 | Nemaline bodies (HP:0003798) | 11.3386283 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 11.0165195 |
| 66 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99798297 |
| 67 | Difficulty climbing stairs (HP:0003551) | 1.98890474 |
| 68 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.94117076 |
| 69 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.94117076 |
| 70 | Lower limb amyotrophy (HP:0007210) | 1.92731440 |
| 71 | Ragged-red muscle fibers (HP:0003200) | 1.90135954 |
| 72 | Exercise intolerance (HP:0003546) | 1.89492002 |
| 73 | Shoulder girdle muscle weakness (HP:0003547) | 1.88741091 |
| 74 | Pelvic girdle muscle weakness (HP:0003749) | 1.88632315 |
| 75 | Foot dorsiflexor weakness (HP:0009027) | 1.85430003 |
| 76 | Heart block (HP:0012722) | 1.84316444 |
| 77 | Paralysis (HP:0003470) | 1.77909694 |
| 78 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.77184719 |
| 79 | Limb-girdle muscle weakness (HP:0003325) | 1.74745255 |
| 80 | Abnormal atrioventricular conduction (HP:0005150) | 1.73086369 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 1.67837874 |
| 82 | Facial diplegia (HP:0001349) | 1.67641683 |
| 83 | Long clavicles (HP:0000890) | 1.63331176 |
| 84 | Metatarsus adductus (HP:0001840) | 1.61747822 |
| 85 | Nonprogressive disorder (HP:0003680) | 1.61283796 |
| 86 | Ulnar deviation of finger (HP:0009465) | 1.60424448 |
| 87 | Increased muscle lipid content (HP:0009058) | 1.55384608 |
| 88 | Ventricular arrhythmia (HP:0004308) | 1.51536484 |
| 89 | Type 2 muscle fiber atrophy (HP:0003554) | 1.45642223 |
| 90 | Popliteal pterygium (HP:0009756) | 1.40420942 |
| 91 | Oligomenorrhea (HP:0000876) | 1.38120706 |
| 92 | Limited hip movement (HP:0008800) | 1.37600020 |
| 93 | Muscle fiber atrophy (HP:0100295) | 1.37268099 |
| 94 | Achilles tendon contracture (HP:0001771) | 1.35728584 |
| 95 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.34795907 |
| 96 | Steppage gait (HP:0003376) | 1.33585555 |
| 97 | Congenital hip dislocation (HP:0001374) | 1.26245607 |
| 98 | Short palpebral fissure (HP:0012745) | 1.24517668 |
| 99 | Adducted thumb (HP:0001181) | 1.23998459 |
| 100 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.21563435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG2 | 6.24201475 |
| 2 | PHKG1 | 6.24201475 |
| 3 | TTN | 6.12804054 |
| 4 | PIK3CG | 2.87971931 |
| 5 | OBSCN | 11.0380098 |
| 6 | MAPK12 | 1.97389216 |
| 7 | PINK1 | 1.91298662 |
| 8 | MAP2K3 | 1.79530390 |
| 9 | MAP3K7 | 1.61084288 |
| 10 | MUSK | 1.48090043 |
| 11 | NME1 | 1.37844734 |
| 12 | MAPKAPK3 | 1.31913944 |
| 13 | NEK1 | 1.23241851 |
| 14 | EEF2K | 1.21063809 |
| 15 | TRPM7 | 1.20453871 |
| 16 | MAP2K4 | 1.16928325 |
| 17 | CCNB1 | 1.08067966 |
| 18 | PDK2 | 1.02589552 |
| 19 | CAMK2G | 0.91255748 |
| 20 | MOS | 0.90723124 |
| 21 | MARK1 | 0.88893342 |
| 22 | MAP2K6 | 0.86617185 |
| 23 | PRKAA2 | 0.84562898 |
| 24 | ERBB3 | 0.84396888 |
| 25 | DMPK | 0.81681115 |
| 26 | LIMK1 | 0.78964242 |
| 27 | DYRK1B | 0.70958552 |
| 28 | PRKAA1 | 0.69022022 |
| 29 | MAP3K13 | 0.66822918 |
| 30 | MAPK7 | 0.60891468 |
| 31 | AKT2 | 0.59178335 |
| 32 | NEK9 | 0.58405656 |
| 33 | CAMK4 | 0.56313341 |
| 34 | BCKDK | 0.53299790 |
| 35 | MAPK11 | 0.52985246 |
| 36 | KSR2 | 0.51059969 |
| 37 | RIPK1 | 0.48115505 |
| 38 | PRKG1 | 0.47956283 |
| 39 | MAP2K1 | 0.47705378 |
| 40 | MAPK4 | 0.47302574 |
| 41 | PKN1 | 0.47261367 |
| 42 | CAMK2D | 0.44246473 |
| 43 | ICK | 0.43632173 |
| 44 | LATS2 | 0.42316702 |
| 45 | TRIB3 | 0.41235961 |
| 46 | SGK3 | 0.41190252 |
| 47 | CAMK2B | 0.40810979 |
| 48 | CAMK2A | 0.39374233 |
| 49 | CAMK1 | 0.37946232 |
| 50 | MAP3K1 | 0.36800250 |
| 51 | PIK3CA | 0.33139982 |
| 52 | RPS6KB2 | 0.31769670 |
| 53 | RPS6KB1 | 0.31462511 |
| 54 | TBK1 | 0.31411903 |
| 55 | ROCK1 | 0.31323971 |
| 56 | TAOK2 | 0.30067041 |
| 57 | PRKACA | 0.29592054 |
| 58 | SGK1 | 0.28172438 |
| 59 | SGK2 | 0.26679752 |
| 60 | TIE1 | 0.26536172 |
| 61 | RPS6KA3 | 0.25346622 |
| 62 | PRPF4B | 0.23874890 |
| 63 | MAPK10 | 0.23745762 |
| 64 | RPS6KA1 | 0.22649054 |
| 65 | MAPK13 | 0.22324300 |
| 66 | PRKACB | 0.21998097 |
| 67 | SIK1 | 0.21816672 |
| 68 | PDPK1 | 0.18800506 |
| 69 | ARAF | 0.17857786 |
| 70 | MARK3 | 0.17235264 |
| 71 | RAF1 | 0.16302217 |
| 72 | MTOR | 0.15223287 |
| 73 | PRKACG | 0.12429455 |
| 74 | CDK19 | 0.12381501 |
| 75 | RPS6KL1 | 0.12181437 |
| 76 | RPS6KC1 | 0.12181437 |
| 77 | PDK1 | 0.11144915 |
| 78 | LATS1 | 0.10934166 |
| 79 | MARK2 | 0.09888905 |
| 80 | BRAF | 0.09231379 |
| 81 | EPHB1 | 0.08761549 |
| 82 | MAP3K11 | 0.08404366 |
| 83 | RPS6KA6 | 0.08078428 |
| 84 | MAP3K10 | 0.07894825 |
| 85 | SGK223 | 0.07679064 |
| 86 | SGK494 | 0.07679064 |
| 87 | DAPK2 | 0.07540388 |
| 88 | STK11 | 0.07367488 |
| 89 | PRKD1 | 0.05990867 |
| 90 | ZAP70 | 0.05182472 |
| 91 | KSR1 | 0.04561370 |
| 92 | GSK3B | 0.03957322 |
| 93 | FGFR3 | 0.03549365 |
| 94 | MAPK3 | 0.02673830 |
| 95 | MAP2K2 | 0.01954183 |
| 96 | MAPK8 | 0.01888694 |
| 97 | MAPK9 | 0.01819501 |
| 98 | PAK1 | 0.01434591 |
| 99 | MAPK14 | 0.00145493 |
| 100 | MAP3K6 | -0.0037848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.31864054 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.10659980 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.07440357 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.04409011 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.76368208 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.70513500 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.04807326 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.78614487 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.41672095 |
| 10 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.36422325 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.20898520 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20328682 |
| 13 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.19741683 |
| 14 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.13538557 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.05413719 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.04908986 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.88270165 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.78715857 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.78631982 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.72964728 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71392437 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71091991 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70340761 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.65839253 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64043731 |
| 26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.56948174 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.48782300 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.40454674 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34739701 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.34004153 |
| 31 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.33947107 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32390740 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30303629 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29652938 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.20261930 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.19137350 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15203679 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00951991 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.00389029 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98042654 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95999456 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88193089 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83555328 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82552695 |
| 45 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81772884 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80878294 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77023994 |
| 48 | Tight junction_Homo sapiens_hsa04530 | 0.73096041 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 0.71834236 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71500788 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69740044 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59273743 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55648002 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54846308 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52989278 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50378527 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46378644 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46040256 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45958317 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.40643425 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39969589 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.39713327 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.39029480 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38484350 |
| 65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37683565 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34902636 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34678269 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34519906 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.34431724 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.32993870 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.30782770 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29400587 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.28342871 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27157772 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27037792 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25963356 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25806052 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25356577 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.22970130 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.22623666 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22437422 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.19765794 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.19405072 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.19314534 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17093399 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16402018 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.15485325 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15421573 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.15106141 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14456977 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.13901646 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12608089 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.09609940 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09230856 |
| 95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.09064391 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.08987847 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.06928454 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06825231 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06519667 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.06410099 |

